The Eppendorf Research plus sets a new standard in high-precision pipetting, displaying superb ergonomics, exceptional versatility and unrivalled durability. Manufactured using the most advanced materials and production processes, the Eppendorf Research plus weighs only 71-75 g, compared with up to 125 g for conventional pipettes.
Every detail of the Research plus has been designed to provide outstanding ease of use, in accordance with the Eppendorf PhysioCare Concept . As well as being extremely lightweight - 75 g or less - risk of RSI is further reduced by the lowest aspirating, dispensing, blow-out and tip ejection forces of any pipette on the market. The spring-loaded tip cone, fast volume adjustment and optimised position and shape of the control buttons and four-digit display make for stress-free workflow and intuitive usage.
Winner of an internationally renowned red dot design award, the Research plus is based on Eppendorf's innovative PerfectPistonâ"žÂ¢ system, made from Fortron . This organic polymer is highly resistant to heat, acids and alkalis, mildew, bleaches, aging, sunlight and abrasion. It absorbs only small amounts of solvents and resists dyeing. The result is a pipette which is safe, robust and fully autoclavable, with no need to recalibrate or re-grease afterwards.
For complete versatility the Eppendorf Research plus is available in a choice of single channel, multi-channel and fixed-volume options in different sizes. It is also simple and quick to calibrate the pipette to handle a dense liquid, such as glycerin, and then re-calibrate back to a normal setting. Features such as the minimal parts design, quick connection clip and individual channel removal on multi-channels facilitate easy maintenance and reduce lifetime service costs.
Eppendorf UK, headquartered in Cambridge, is a subsidiary of Eppendorf AG, Hamburg, Germany, a leading global supplier of systems and research tools for the biotechnology industry. With over 2400 employees on four continents, Eppendorf AG achieved a turnover of £241m (Euro 346m) in 2007 and operating profits (EBIT) of £44m (â"šÂ¬62.5m).